Providing oncology drug developers with the successful delivery of early phase oncology studies. Slough, Berkshire, United Kingdom: Simbec-Orion announced a ...Read more >
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. ...Read more >
Simbec-Orion COVID-19 Update 1 April 2020
As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from ...Read more >
Developing new drugs is a rigorous and detailed process, requiring close scrutiny and testing across clinical trials in order for ...Read more >
Clinical research helps develop new evidence-based approaches to treating health conditions, resulting in better, safer and more effective treatments. However, ...Read more >
Celebrating success across life sciences London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised ...Read more >
